Pitcairn Co. grew its position in Ambev S.A. (NYSE:ABEV – Free Report) by 80.1% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 177,773 shares of the company’s stock after purchasing an additional 79,038 shares during the period. Pitcairn Co.’s holdings in Ambev were worth $434,000 as of its most recent filing with the SEC.
Several other large investors have also made changes to their positions in the company. Prime Capital Investment Advisors LLC grew its holdings in shares of Ambev by 37.9% during the third quarter. Prime Capital Investment Advisors LLC now owns 17,685 shares of the company’s stock worth $43,000 after purchasing an additional 4,861 shares during the last quarter. National Bank of Canada FI increased its position in Ambev by 25.0% in the 2nd quarter. National Bank of Canada FI now owns 24,489 shares of the company’s stock valued at $50,000 after acquiring an additional 4,900 shares in the last quarter. UMB Bank n.a. raised its stake in shares of Ambev by 37.4% in the third quarter. UMB Bank n.a. now owns 18,324 shares of the company’s stock worth $45,000 after acquiring an additional 4,984 shares during the last quarter. Endowment Wealth Management Inc. lifted its position in shares of Ambev by 26.1% during the second quarter. Endowment Wealth Management Inc. now owns 25,933 shares of the company’s stock worth $53,000 after purchasing an additional 5,368 shares in the last quarter. Finally, PDS Planning Inc grew its stake in shares of Ambev by 18.4% during the third quarter. PDS Planning Inc now owns 34,870 shares of the company’s stock valued at $85,000 after purchasing an additional 5,409 shares during the last quarter. Institutional investors own 8.13% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on ABEV shares. StockNews.com assumed coverage on shares of Ambev in a research report on Friday, October 18th. They issued a “buy” rating for the company. UBS Group dropped their target price on Ambev from $3.20 to $2.90 and set a “buy” rating for the company in a research report on Wednesday, July 31st. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $2.70.
Ambev Price Performance
ABEV opened at $2.19 on Wednesday. The company has a fifty day moving average price of $2.29 and a two-hundred day moving average price of $2.24. The firm has a market capitalization of $34.50 billion, a PE ratio of 12.17, a P/E/G ratio of 6.82 and a beta of 1.06. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.89 and a current ratio of 1.20. Ambev S.A. has a 52 week low of $2.01 and a 52 week high of $3.00.
About Ambev
Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith’s, and Kokanee brands.
Recommended Stories
- Five stocks we like better than Ambev
- NYSE Stocks Give Investors a Variety of Quality Options
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- Transportation Stocks Investing
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- What is a SEC Filing?
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Ambev Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambev and related companies with MarketBeat.com's FREE daily email newsletter.